Cargando…

Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery

BACKGROUND: Prediction of prognosis for patients with esophageal cancer(EC) is beneficial for their postoperative clinical decision-making. This study’s goal was to create a dependable machine learning (ML) model for predicting the prognosis of patients with EC after surgery. METHODS: The files of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jinye, Zhou, Jianghui, Hu, Junxi, Ren, Qinglin, Wang, Xiaolin, Shu, Yusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780661/
https://www.ncbi.nlm.nih.gov/pubmed/36568178
http://dx.doi.org/10.3389/fonc.2022.1068198
_version_ 1784856886411001856
author Xu, Jinye
Zhou, Jianghui
Hu, Junxi
Ren, Qinglin
Wang, Xiaolin
Shu, Yusheng
author_facet Xu, Jinye
Zhou, Jianghui
Hu, Junxi
Ren, Qinglin
Wang, Xiaolin
Shu, Yusheng
author_sort Xu, Jinye
collection PubMed
description BACKGROUND: Prediction of prognosis for patients with esophageal cancer(EC) is beneficial for their postoperative clinical decision-making. This study’s goal was to create a dependable machine learning (ML) model for predicting the prognosis of patients with EC after surgery. METHODS: The files of patients with esophageal squamous cell carcinoma (ESCC) of the thoracic segment from China who received radical surgery for EC were analyzed. The data were separated into training and test sets, and prognostic risk variables were identified in the training set using univariate and multifactor COX regression. Based on the screened features, training and validation of five ML models were carried out through nested cross-validation (nCV). The performance of each model was evaluated using Area under the curve (AUC), accuracy(ACC), and F1-Score, and the optimum model was chosen as the final model for risk stratification and survival analysis in order to build a valid model for predicting the prognosis of patients with EC after surgery. RESULTS: This study enrolled 810 patients with thoracic ESCC. 6 variables were ultimately included for modeling. Five ML models were trained and validated. The XGBoost model was selected as the optimum for final modeling. The XGBoost model was trained, optimized, and tested (AUC = 0.855; 95% CI, 0.808-0.902). Patients were separated into three risk groups. Statistically significant differences (p < 0.001) were found among all three groups for both the training and test sets. CONCLUSIONS: A ML model that was highly practical and reliable for predicting the prognosis of patients with EC after surgery was established, and an application to facilitate clinical utility was developed.
format Online
Article
Text
id pubmed-9780661
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97806612022-12-24 Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery Xu, Jinye Zhou, Jianghui Hu, Junxi Ren, Qinglin Wang, Xiaolin Shu, Yusheng Front Oncol Oncology BACKGROUND: Prediction of prognosis for patients with esophageal cancer(EC) is beneficial for their postoperative clinical decision-making. This study’s goal was to create a dependable machine learning (ML) model for predicting the prognosis of patients with EC after surgery. METHODS: The files of patients with esophageal squamous cell carcinoma (ESCC) of the thoracic segment from China who received radical surgery for EC were analyzed. The data were separated into training and test sets, and prognostic risk variables were identified in the training set using univariate and multifactor COX regression. Based on the screened features, training and validation of five ML models were carried out through nested cross-validation (nCV). The performance of each model was evaluated using Area under the curve (AUC), accuracy(ACC), and F1-Score, and the optimum model was chosen as the final model for risk stratification and survival analysis in order to build a valid model for predicting the prognosis of patients with EC after surgery. RESULTS: This study enrolled 810 patients with thoracic ESCC. 6 variables were ultimately included for modeling. Five ML models were trained and validated. The XGBoost model was selected as the optimum for final modeling. The XGBoost model was trained, optimized, and tested (AUC = 0.855; 95% CI, 0.808-0.902). Patients were separated into three risk groups. Statistically significant differences (p < 0.001) were found among all three groups for both the training and test sets. CONCLUSIONS: A ML model that was highly practical and reliable for predicting the prognosis of patients with EC after surgery was established, and an application to facilitate clinical utility was developed. Frontiers Media S.A. 2022-12-09 /pmc/articles/PMC9780661/ /pubmed/36568178 http://dx.doi.org/10.3389/fonc.2022.1068198 Text en Copyright © 2022 Xu, Zhou, Hu, Ren, Wang and Shu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Xu, Jinye
Zhou, Jianghui
Hu, Junxi
Ren, Qinglin
Wang, Xiaolin
Shu, Yusheng
Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
title Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
title_full Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
title_fullStr Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
title_full_unstemmed Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
title_short Development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
title_sort development and validation of a machine learning model for survival risk stratification after esophageal cancer surgery
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780661/
https://www.ncbi.nlm.nih.gov/pubmed/36568178
http://dx.doi.org/10.3389/fonc.2022.1068198
work_keys_str_mv AT xujinye developmentandvalidationofamachinelearningmodelforsurvivalriskstratificationafteresophagealcancersurgery
AT zhoujianghui developmentandvalidationofamachinelearningmodelforsurvivalriskstratificationafteresophagealcancersurgery
AT hujunxi developmentandvalidationofamachinelearningmodelforsurvivalriskstratificationafteresophagealcancersurgery
AT renqinglin developmentandvalidationofamachinelearningmodelforsurvivalriskstratificationafteresophagealcancersurgery
AT wangxiaolin developmentandvalidationofamachinelearningmodelforsurvivalriskstratificationafteresophagealcancersurgery
AT shuyusheng developmentandvalidationofamachinelearningmodelforsurvivalriskstratificationafteresophagealcancersurgery